Dr Chen-Yueh Kenny Wen

MD

  • Department:
  • University: Department of Medicine, Tzu Chi University
  • Country: Taiwan

Dr. Chen-Yueh Kenny Wen is a skilled urologist specializing in minimally invasive urological surgery, endoscopic management of prostate and urinary tract disorders, and robotic surgical approaches. His research focuses on prostate cancer, renal cell carcinoma, natural compounds with therapeutic potential, and bioinformatics-based drug target discovery.

He has trained at leading medical centers including Kaohsiung Veterans General Hospital and Hong Kong Prince of Wales Hospital, and currently serves as a Urologist at Changhua Show Chwan Memorial Hospital, Taiwan. His scholarly work includes multiple publications in high-impact clinical and pharmacological journals, advancing precision oncology and urologic therapeutics.

  • Numerous first-author and co-author research publications

  • Presenter at UAA, AUA, EAU, and JUA conferences

  • Active member of:

    • Taiwan Urological Association

    • Urological Association of Asia

    • European Association of Urology

  • ACOX1 in cancer and immunity: Unraveling its complex interplay.
    Pharmacological Research (2024); 205:107241.

  • CSF-1R: A promising therapeutic target for various diseases.
    Pharmacological Research (2024); 204:107196.

  • The dual role of NSD2 in mitochondrial function: Insights into interstitial fibrosis and renal cancer.
    Pharmacological Research (2024); 207:107320.

  • Targeting EVA1B in breast cancer: New avenues for precision oncology.
    Pharmacological Research (2025); 214:107684.

  • Mechanometabolic Regulation in Cancer Progression: Lessons from Fibrotic Remodeling.
    International Journal of Biological Sciences (2025); 21(6):2672-5.

  • WTAP's Dual Role in Disease: Orchestrating Inflammation in Rheumatoid Arthritis and Challenging Renal Clear Cell Carcinoma Outcomes.
    International Journal of Rheumatic Diseases (2025); 28(5):e70248.

  • Single-cell landscape and spatial transcriptomic analysis reveals macrophage infiltration and glycolytic metabolism in kidney renal clear cell carcinoma.
    Aging (Albany NY) (2023); 15.

  • Phloretin in Benign Prostate Hyperplasia and Prostate Cancer: A Contemporary Systematic Review.
    Life (2022); 12:1029.